309 related articles for article (PubMed ID: 20668078)
1. P body-associated protein Mov10 inhibits HIV-1 replication at multiple stages.
Burdick R; Smith JL; Chaipan C; Friew Y; Chen J; Venkatachari NJ; Delviks-Frankenberry KA; Hu WS; Pathak VK
J Virol; 2010 Oct; 84(19):10241-53. PubMed ID: 20668078
[TBL] [Abstract][Full Text] [Related]
2. Mov10 and APOBEC3G localization to processing bodies is not required for virion incorporation and antiviral activity.
Izumi T; Burdick R; Shigemi M; Plisov S; Hu WS; Pathak VK
J Virol; 2013 Oct; 87(20):11047-62. PubMed ID: 23926332
[TBL] [Abstract][Full Text] [Related]
3. Moloney leukemia virus 10 (MOV10) inhibits the degradation of APOBEC3G through interference with the Vif-mediated ubiquitin-proteasome pathway.
Chen C; Ma X; Hu Q; Li X; Huang F; Zhang J; Pan T; Xia J; Liu C; Zhang H
Retrovirology; 2017 Dec; 14(1):56. PubMed ID: 29258557
[TBL] [Abstract][Full Text] [Related]
4. Endogenous MOV10 inhibits the retrotransposition of endogenous retroelements but not the replication of exogenous retroviruses.
Arjan-Odedra S; Swanson CM; Sherer NM; Wolinsky SM; Malim MH
Retrovirology; 2012 Jun; 9():53. PubMed ID: 22727223
[TBL] [Abstract][Full Text] [Related]
5. Moloney leukemia virus 10 (MOV10) protein inhibits retrovirus replication.
Wang X; Han Y; Dang Y; Fu W; Zhou T; Ptak RG; Zheng YH
J Biol Chem; 2010 May; 285(19):14346-55. PubMed ID: 20215113
[TBL] [Abstract][Full Text] [Related]
6. APOBEC3G inhibits microRNA-mediated repression of translation by interfering with the interaction between Argonaute-2 and MOV10.
Liu C; Zhang X; Huang F; Yang B; Li J; Liu B; Luo H; Zhang P; Zhang H
J Biol Chem; 2012 Aug; 287(35):29373-83. PubMed ID: 22791714
[TBL] [Abstract][Full Text] [Related]
7. GANP interacts with APOBEC3G and facilitates its encapsidation into the virions to reduce HIV-1 infectivity.
Maeda K; Almofty SA; Singh SK; Eid MMA; Shimoda M; Ikeda T; Koito A; Pham P; Goodman MF; Sakaguchi N
J Immunol; 2013 Dec; 191(12):6030-6039. PubMed ID: 24198285
[TBL] [Abstract][Full Text] [Related]
8. Perturbation of the P-body component Mov10 inhibits HIV-1 infectivity.
Furtak V; Mulky A; Rawlings SA; Kozhaya L; Lee K; Kewalramani VN; Unutmaz D
PLoS One; 2010 Feb; 5(2):e9081. PubMed ID: 20140200
[TBL] [Abstract][Full Text] [Related]
9. Distinct viral determinants for the packaging of human cytidine deaminases APOBEC3G and APOBEC3C.
Wang T; Zhang W; Tian C; Liu B; Yu Y; Ding L; Spearman P; Yu XF
Virology; 2008 Jul; 377(1):71-9. PubMed ID: 18495196
[TBL] [Abstract][Full Text] [Related]
10. UPF1 is crucial for the infectivity of human immunodeficiency virus type 1 progeny virions.
Serquiña AK; Das SR; Popova E; Ojelabi OA; Roy CK; Göttlinger HG
J Virol; 2013 Aug; 87(16):8853-61. PubMed ID: 23785196
[TBL] [Abstract][Full Text] [Related]
11. RNA helicase MOV10 functions as a co-factor of HIV-1 Rev to facilitate Rev/RRE-dependent nuclear export of viral mRNAs.
Huang F; Zhang J; Zhang Y; Geng G; Liang J; Li Y; Chen J; Liu C; Zhang H
Virology; 2015 Dec; 486():15-26. PubMed ID: 26379090
[TBL] [Abstract][Full Text] [Related]
12. Intracellular interactions between APOBEC3G, RNA, and HIV-1 Gag: APOBEC3G multimerization is dependent on its association with RNA.
Friew YN; Boyko V; Hu WS; Pathak VK
Retrovirology; 2009 Jun; 6():56. PubMed ID: 19497112
[TBL] [Abstract][Full Text] [Related]
13. The anti-HIV-1 editing enzyme APOBEC3G binds HIV-1 RNA and messenger RNAs that shuttle between polysomes and stress granules.
Kozak SL; Marin M; Rose KM; Bystrom C; Kabat D
J Biol Chem; 2006 Sep; 281(39):29105-19. PubMed ID: 16887808
[TBL] [Abstract][Full Text] [Related]
14. Effect of P-body component Mov10 on HCV virus production and infectivity.
Liu D; Ndongwe TP; Puray-Chavez M; Casey MC; Izumi T; Pathak VK; Tedbury PR; Sarafianos SG
FASEB J; 2020 Jul; 34(7):9433-9449. PubMed ID: 32496609
[TBL] [Abstract][Full Text] [Related]
15. Identification of molecular determinants from Moloney leukemia virus 10 homolog (MOV10) protein for virion packaging and anti-HIV-1 activity.
Abudu A; Wang X; Dang Y; Zhou T; Xiang SH; Zheng YH
J Biol Chem; 2012 Jan; 287(2):1220-8. PubMed ID: 22105071
[TBL] [Abstract][Full Text] [Related]
16. APOBEC3G-independent reduction in virion infectivity during long-term HIV-1 replication in terminally differentiated macrophages.
Miyagi E; Schwartzkopff F; Plishka R; Buckler-White A; Clouse KA; Strebel K
Virology; 2008 Sep; 379(2):266-74. PubMed ID: 18675436
[TBL] [Abstract][Full Text] [Related]
17. Functional domain organization of human APOBEC3G.
Gooch BD; Cullen BR
Virology; 2008 Sep; 379(1):118-24. PubMed ID: 18639915
[TBL] [Abstract][Full Text] [Related]
18. APOBEC3G and APOBEC3F require an endogenous cofactor to block HIV-1 replication.
Han Y; Wang X; Dang Y; Zheng YH
PLoS Pathog; 2008 Jul; 4(7):e1000095. PubMed ID: 18604271
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of Enhanced HIV Restriction by Virion Coencapsidated Cytidine Deaminases APOBEC3F and APOBEC3G.
Ara A; Love RP; Follack TB; Ahmed KA; Adolph MB; Chelico L
J Virol; 2017 Feb; 91(3):. PubMed ID: 27881650
[TBL] [Abstract][Full Text] [Related]
20. APOBEC3G-Regulated Host Factors Interfere with Measles Virus Replication: Role of REDD1 and Mammalian TORC1 Inhibition.
Tiwarekar V; Wohlfahrt J; Fehrholz M; Scholz CJ; Kneitz S; Schneider-Schaulies J
J Virol; 2018 Sep; 92(17):. PubMed ID: 29925665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
